Scientists Shed Light on ‘Critical’ Impact of TDP-43 Protein in ALS
Two independent teams of scientists have unraveled the molecular mechanism by which abnormal localization of the TDP-43 protein, which is…
Articles by Marisa Wexler, MS
#MDA2022 – NurOwn May Benefit Patients With Specific Gene Variant
Treatment with the cell therapy NurOwn may slow the progression of amyotrophic lateral sclerosis (ALS) for those with…
#MDA2022 – CNM-Au8 May Slow Progression, Reduce Risk of Death
Treatment with Clene Nanomedicine’s experimental medicine CNM-Au8 may decrease the risk of disease progression or death in people with…
BMAA, Formaldehyde Among Toxins in Environment Linked to ALS Risk
Exposure to certain toxic compounds — including beta-N-methylamino-L-alanine (BMAA), formaldehyde, and heavy metals like manganese, mercury, and zinc — increases…
In FUS-ALS Cell Model, Circular RNA ‘Trapped’ in Toxic Protein Clumps
Mutations in the FUS gene, which cause some forms of amyotrophic lateral sclerosis (ALS), result in a circular RNA…
London-based CERF Prizes Benefit U.S.-based Research
The Cullen Education and Research Fund (CERF), a private philanthropy based in London, has awarded more than $800,000 to support…
Structure of TDP-43 Protein Clumps Identified for First Time
A team of scientists in the U.K. and Japan has determined the structure of aggregated TDP-43, the protein whose abnormal clumps…
Oral Edaravone Under FDA Priority Review, Decision Expected in May
A decision is expected by May from the U.S. Food and Drug Administration (FDA) on an application seeking approval of…
Top 10 ALS Stories of 2021
ALS News Today brought you daily coverage of the latest scientific breakthroughs and clinical research related to amyotrophic…
Risk of ALS Increases Nearly Fourfold in NFL Players
Athletes who have played in the National Football League (NFL) are significantly more likely than the general population to develop…